Haleon plc (HLN) |
|
8.17 -0.2 (-2.39%)
|
03-24 16:00 |
|
Open: |
8.24 |
Pre. Close: |
8.37 |
|
High:
|
8.27 |
Low:
|
8.12 |
|
Volume:
|
9,771,501 |
Market Cap:
|
37,723(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:26:44 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 9.8 One year: 11.45 |
| Support: |
Support1: 7.83 Support2: 7.48 |
| Resistance: |
Resistance1: 8.39 Resistance2: 9.8 |
| Pivot: |
7.92  |
| Moving Average: |
MA(5): 8.16 MA(20): 7.89
MA(100): 7.59 MA(250): 0 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 84.5 %D(3): 89.1 |
| RSI: |
RSI(14): 56.8 |
| 52-week: |
High: 8.39 Low: 5.59 |
| Average Vol(K): |
3-Month: 4,846 (K) 10-Days: 6,788 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HLN ] has closed below upper band by 20.6%. Bollinger Bands are 29.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
8.28 - 8.32 |
8.32 - 8.35 |
|
Low:
|
8.02 - 8.08 |
8.08 - 8.11 |
|
Close:
|
8.09 - 8.17 |
8.17 - 8.23 |
|
Company Description |
|
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. |
Headline News |
Sun, 26 Mar 2023
Guru Fundamental Report for HLN - Martin Zweig - Nasdaq
Sun, 26 Mar 2023
JTC Employer Solutions Trustee Ltd acquires 62,147 Haleon plc ... - Best Stocks
Sun, 26 Mar 2023
BLB&B Advisors LLC Makes New Investment in Haleon plc (NYSE ... - MarketBeat
Sun, 26 Mar 2023
Insiders who bought Haleon plc (LON:HLN) last year must be regretting not buying more as market cap hits UK£30b - Yahoo Eurosport UK
Sat, 25 Mar 2023
JTC Employer Solutions Trustee Ltd Buys 62147 Shares of Haleon ... - MarketBeat
Wed, 22 Mar 2023
Haleon plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Simply Wall St
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
4,620 (M) |
| Shares Float |
2,530 (M) |
|
% Held by Insiders
|
6.4 (%) |
|
% Held by Institutions
|
7.3 (%) |
|
Shares Short
|
17,810 (K) |
|
Shares Short P.Month
|
13,120 (K) |
Stock Financials |
|
EPS
|
0.28 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
3.53 |
|
Profit Margin (%)
|
9.7 |
|
Operating Margin (%)
|
21.9 |
|
Return on Assets (ttm)
|
4.3 |
|
Return on Equity (ttm)
|
5.2 |
|
Qtrly Rev. Growth
|
12 |
|
Gross Profit (p.s.)
|
1.45 |
|
Sales Per Share
|
2.35 |
|
EBITDA (p.s.)
|
0.55 |
|
Qtrly Earnings Growth
|
-62.5 |
|
Operating Cash Flow
|
2,060 (M) |
|
Levered Free Cash Flow
|
3,390 (M) |
Stock Valuations |
|
PE Ratio
|
29.17 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.3 |
|
Price to Sales
|
3.47 |
|
Price to Cash Flow
|
18.32 |
Stock Dividends |
|
Dividend
|
0.05 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.7% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
